nephritic syndrome
hematuria, azotemia, variable proteinuria, oliguria, edema, HTN
nephrotic syndrome
> 3.5g/day proteinuria, hypoalbuminemia, hyperlipidemia, lipiduria
subepi hump
PSGN
subepi deposits (spikes and domes)
membranous nephropathy
mesangial deposits
IgA nephropathy
C3 glomerulopathy
early lupus nephritis
subendo deposits, tram track
MPGN
lupus nephritis
crescentic/RPGN types
I - anti-GBM Ab mediated (Goodpasture)
II - immune complex mediated
III - pauci-immune (ANCA)
membranous nephropathy antigen
PLA2R
Ab in minimal change and FSGS
anti-nephrin Ab
dysregulation of alternative complement
DDD/C3 glomerulonephritis (previously MPGN II)
c-ANCA and p-ANCA other names
c-ANCA - PR3-ANCA
p-ANCA - MPO-ANCA
lipoid nephrosis
minimal change dse
allele in Africans assoc. with FSGS, HIV-assoc, COVID-19
what variant
APOL1
collapsing variant
inherited FSGS gene
congenital nephrotic syndrome of Finnish type
NPHS1 (nephrin)
inherited FSGS gene
AR
steroid-resistant nephrotic syndrome of childhood onset
NPHS2
AD FSGS
ACTN4 (a-actinin 4)
INF2 (inverted formin 2)
adult onset FSGS
TRP6
biomarker of DDD
apo E
intramembranous dense deposits
C3 glomerulopathies inc. DDD
assoc. with celiac dse
IgA neph
basket weave on EM
Alport
X-linked
thin basement membrane neph
lupus nephritis
I - minimal mesangial -LC
II - mesangial prolif
III - focal - mesangial + endo, <50%, RBC cast
IV - diffuse - MC, mesangial + endo + epi, >50%, wire loop
V - membranous - diffuse thickening of capillary walls
VI - advanced sclerosing - 90%
essential mixed cryoglobulinemia
Hep C
MPGN
NSAID glomerulopathies
minimal change dse, membranous nephropathy